Skip to main content

Publications

featured publications

  • Two-center validation of assays for the detection of binding and neutralizing anti-factor VIII antibodies.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Jens Müller, Sonja Neimanis, Jörg Kahle, Thilo Albert, Stephan Schultze Strasser, Bonita Rup, Bernd Pötzsch, Christoph Königs, Johannes Oldenburg

  • Heterozygosity in FXIII genes and the manifestation of mild inherited FXIII Deficiency.

    Journal of thrombosis and haemostasis : JTH

    Authors: Sneha Singh, Behnaz Pezeshkpoor, Muhammad Ahmer Jamil, Johannes Dodt, Amit Sharma, Vasanth Ramar, Vytautas Ivaskevicius, Emma Hethershaw, Helen Philippou, Anna Pavlova, Johannes Oldenburg, Arijit Biswas

  • Functional determination of emicizumab in presence of Factor VIII activity.

    Journal of thrombosis and haemostasis : JTH

    Authors: Nasim Shahidi Hamedani, Anouk Anna Marie Therese Donners, Matthijs van Luin, Simone Gasper, Heiko Rühl, Claudia Klein, Thilo Albert, Mohsin El Amrani, Bernd Pötzsch, Johannes Oldenburg, Jens Müller

  • Cases of less-than-expected FVIII activity in previously treated patients during post-marketing surveillance of N8-GP.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Johannes Oldenburg, Gary Benson, Pratima Chowdary, Susan Halimeh, Tadashi Matsushita, Anne Nørland, Mohd Nawi Wahid, Laszlo Nemes

  • Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults.

    Research and practice in thrombosis and haemostasis

    Authors: Barbara A Konkle, Johannes Oldenburg, John Pasi, Roshni Kulkarni, Beatrice Nolan, Johnny Mahlangu, Guy Young, Simon A Brown, Ingrid Pabinger, Amy Shapiro, Claude Négrier, Victor Blanchette, Margaret V Ragni, Jennifer Dumont, Stefan Lethagen

  • Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study.

    Therapeutic advances in hematology

    Authors: Carmen Escuriola Ettingshausen, Cedric Hermans, Pål A Holme, Ana R Cid, Kate Khair, Johannes Oldenburg, Claude Négrier, Jaco Botha, Aurelia Lelli, Jerzy Windyga

  • Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.

    European journal of haematology

    Authors: Mary Mathias, Aby Abraham, Mark J Belletrutti, Manuel Carcao, Manuela Carvalho, Hervé Chambost, Anthony K C Chan, Leonid Dubey, Jonathan Ducore, Michael Gattens, Paolo Gresele, Yves Gruel, Benoit Guillet, Victor Jiménez-Yuste, Lidija Kitanovski, Anna Klukowska, Sunil Lohade, Maria Elisa Mancuso, Johannes Oldenburg, Berardino Pollio, Marianne Sigaud, Kateryna Vilchevska, John K M Wu, Martina Jansen, Larisa Belyanskaya, Olaf Walter, Sigurd Knaub, Ellis J Neufeld

  • Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries.

    Advances in therapy

    Authors: Eva Funding, Gillian Lowe, Lone H Poulsen, Susan Shapiro, Johannes Oldenburg, Daniel Eriksson, Aletta Falk, Carly Rich

  • Design of a Real-World Observational Study in Previously Untreated and Minimally Treated Hemophilia A Patients: Protect-NOW.

    TH open : companion journal to thrombosis and haemostasis

    Authors: Johannes Oldenburg, Susan Halimeh, Georgina W Hall, Robert Klamroth, Pascual Marco Vera, Martina Jansen, Mary Mathias

  • Antidrug antibodies against the polyethylene glycol moiety inhibit the procoagulant activity of therapeutic polyethylene glycolated factor VIII.

    Journal of thrombosis and haemostasis : JTH

    Authors: Behnaz Pezeshkpoor, Nadja Sereda, Ann-Cristin Berkemeier, Isabell Matuschek, Nadine Schwarz, Peter L Turecek, Silvia Horneff, Claudia Klein, Georg Goldmann, Natascha Marquardt, Thilo Albert, Jens Müller, Johannes Oldenburg